Target intelligence / Profile preview

Forkhead box protein O (FOXO) transcription factors (FOXO)

Target
FOXO
Molecular classification
Transcription factor, Forkhead box family, Helix-turn-helix protein
01

Overview

Forkhead box protein O (FOXO) transcription factors are a conserved family of proteins, including FOXO1, FOXO3, FOXO4, and FOXO6, that play a central role in maintaining cellular homeostasis by regulating genes involved in cell cycle arrest, apoptosis, and oxidative stress resistance [1, 5, 15]. They act as critical downstream effectors of the PI3K/Akt/mTOR signaling pathway, where phosphorylation by Akt leads to their nuclear export and inactivation [10, 12]. When active in the nucleus, FOXO factors function as tumor suppressors by inducing programmed cell death and inhibiting proliferation in response to stress [5, 16]. Beyond oncology, FOXO1 is a major regulator of hepatic gluconeogenesis and insulin sensitivity, while FOXO3 is strongly associated with human longevity and stem cell maintenance [8, 10, 13]. Therapeutic strategies currently explore activating FOXO to combat cancer and aging-related diseases, or inhibiting specific isoforms like FOXO1 to treat metabolic disorders such as type 2 diabetes [3, 10].

Other names
Forkhead box Class OForkhead in rhabdomyosarcoma (FKHR)FKHRL1AFXAF6q21DAF-16
02

Mechanism of action

Inhibition of nuclear export via PI3K/Akt pathway inhibition to promote transcriptional activity; Direct inhibition of FOXO1 DNA binding; Disruption of protein-protein interactions (e.g., FOXO4-p53) to induce apoptosis in senescent cells.

03

Biological functions

ApoptosisCell cycle regulationOxidative stress responseMetabolic regulationLongevityAutophagyDNA repairImmune response
04

Disease associations

CancerType 2 diabetesNeurodegenerative diseaseAging-related diseaseCardiovascular diseaseInflammation
05

Safety considerations

Risk of stem cell exhaustion from chronic over-activationDual role in cancer where FOXO can promote survival in certain chemoresistant contextsPleiotropic metabolic and immune side effects due to systemic modulationDevelopmental toxicity (FOXO1 is essential for embryonic vascular development)
06

Interacting drugs

AS1842856

6 more in the full profile.

07

Biomarkers

FOXO phosphorylation status (e.g., p-FOXO1, p-FOXO3)Nuclear localization levelsManganese superoxide dismutase (MnSOD) expressionBim expressionFas ligand (FasL) expression

Beyond the preview

Go deeper on Forkhead box protein O (FOXO) transcription factors (FOXO).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box protein O (FOXO) transcription factors (FOXO).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call